Association of Burkitt's lymphoma with the Epstein-Barr virus in two developing countries

被引:22
|
作者
Rao, CR [1 ]
Gutierrez, MI [1 ]
Bhatia, K [1 ]
Fend, F [1 ]
Franklin, J [1 ]
Appaji, L [1 ]
Gallo, G [1 ]
O'Conor, G [1 ]
Lalitha, N [1 ]
Magrath, I [1 ]
机构
[1] NCI, Pediat Branch, Lymphoma Biol Sect, Bethesda, MD 20892 USA
关键词
Burkitt's lymphoma; Epstein-Barr virus; India; Argentina; EBV subtype; LMP-1; deletion;
D O I
10.3109/10428190009065832
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The clinical presentation of Burkitt's lymphoma (BL) and it's association with the Epstein-Barr virus (EBV) varies in different geographic areas, BL in developing countries being "intermediate" between the sporadic and endemic types, both in it's clinical presentation and it's association with EBV, which varies from 25-80%. In this study we have analysed the clinical features, EBV association, subtype and prevalence of the deleted variant of the Latent Membrane Protein-1 (LMP-1) of EBV in forty-two cases from two developing countries- India (n=25) and Argentina (n=17). In both countries the abdomen was the site most commonly involved while jaw involvement was rare. EBV was detected by in-situ hybridization using the EBER-1 RNA probe. 47% of cases from Argentina and 80% of cases from India were EBER positive. EBV typing using EBNA-3C primers showed a predominance of Type A in both countries (India-13/16 and Argentina-7/8). The 30bp deletion of the LMP-1 gene was detected in all evaluated cases from Argentina while the wild type of the gene was seen in all the evaluable Indian cases. Our study highlights the similarities and differences in the clinical presentation and EBV association of BL in two developing countries and also indicates that the subtype of EBV and prevalence of the LMP-1 deletion may reflect the pre dominant subtype in a particular population.
引用
收藏
页码:329 / +
页数:10
相关论文
共 50 条
  • [31] A brief overview of the Epstein Barr virus and its association with Burkitt's lymphoma
    Farzanehpour, Mahdieh
    Fard, Amir M. M.
    Ghaleh, Hadi E. G.
    ROMANIAN JOURNAL OF MILITARY MEDICINE, 2022, 125 (03) : 373 - 381
  • [32] Burkitt's lymphoma in Jordan: An intermediate rate of Epstein Barr virus association
    Khalidi, HS
    Habashneh, M
    Abu-Jabbarah, SF
    Almasri, NM
    LABORATORY INVESTIGATION, 2001, 81 (01) : 168A - 168A
  • [33] Burkitt's lymphoma in Jordan: An intermediate rate of Epstein Barr virus association
    Khalidi, HS
    Habashneh, M
    Abu-Jabbarah, SF
    Almasri, NM
    MODERN PATHOLOGY, 2001, 14 (01) : 168A - 168A
  • [34] Epstein-Barr virus and the somatic hypermutation of immunoglobulin genes in Burkitt's lymphoma cells
    Harris, RS
    Croom-Carter, DSG
    Rickinson, AB
    Neuberger, MS
    JOURNAL OF VIROLOGY, 2001, 75 (21) : 10488 - 10492
  • [35] Detection of Epstein-Barr virus integration loci in Burkitt's lymphoma cell lines
    Penas, E. Murga
    Hinke, J.
    Schilling, G.
    Behrmann, P.
    Klokow, M.
    Albert, N.
    Bokemeyer, C.
    Dierlamm, J.
    ANNALS OF ONCOLOGY, 2008, 19 : 166 - 166
  • [36] Epstein-Barr virus and its role in the pathogenesis of Burkitt's lymphoma: An unresolved issue
    Bornkamm, Georg W.
    SEMINARS IN CANCER BIOLOGY, 2009, 19 (06) : 351 - 365
  • [37] Replacement of the Epstein-Barr virus plasmid with the EBER plasmid in Burkitt's lymphoma cells
    Maruo, S
    Nanbo, A
    Takada, K
    JOURNAL OF VIROLOGY, 2001, 75 (20) : 9977 - 9982
  • [38] Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: More questions than answers
    Bornkamm, Georg W.
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (08) : 1745 - 1755
  • [39] Expression of Epstein-Barr virus gene products in Burkitt's lymphoma in Northeast Brazil
    Araujo, I
    Foss, HD
    Bittencourt, A
    Hummel, M
    Demel, G
    Mendonca, N
    Herbst, H
    Stein, H
    BLOOD, 1996, 87 (12) : 5279 - 5286
  • [40] Friend or foe: association of Euphorbia spp. with Epstein-Barr virus and Burkitt's lymphoma, an in silico approach
    Erdag, Emine
    Ersalici, Ismet
    Ozverel, Cenk Serhan
    FUTURE VIROLOGY, 2023, 18 (09) : 583 - 594